Johnson & Johnson has underperformed its lerge-cap healthcare peers and the S&P 500, with an -8% decline over the past year.
Johnson & Johnson JNJ1.70%increase; green up pointing triangle agreed to acquire mental-illness drug developer ...
Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...
Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through ...
Minority owner Tom Brady could bump into some of the Raiders' top coaching and GM candidates before his broadcast this ...
These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...